New, key players in the pathobiology of pancreatic cancer
  • Karen E. Hedin
Review Article


The chemokines are a family of peptide hormones that regulate cellular adhesion, migration, proliferation, and survival. Accumulating evidence indicates critical regulatory roles for chemokines during the development of hyperplasias and metastatic tumors. Chemokines promote tumor metastasis, growth, survival, and angiogenesis. In addition, by regulating immunity, chemokines critically regulate anti-tumor immune responses and chronic inflammation such as that associated with various neoplasias. Since chemokine receptors are G-protein coupled receptors that are ideal drug targets, these discoveries presage the development of new and potent anti-cancer drugs that target chemokine receptors. Here, I review the chemokine system and chemokine regulation of neoplasias, with a special emphasis on pancreatic cancer.

Key Words

Chemokines pancreas cancer G proteins signaling 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002;2:106–115.PubMedCrossRefGoogle Scholar
  2. 2.
    Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001;14:377–386.PubMedCrossRefGoogle Scholar
  3. 3.
    Thelen M. Dancing to the tune of chemokines. Nat Immunol 2001;2:129–134.PubMedCrossRefGoogle Scholar
  4. 4.
    Cascieri MA, Springer MS. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000;4:420–427.PubMedCrossRefGoogle Scholar
  5. 5.
    Marinissen MJ, Gutkind JS. G protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001;22:368–376.PubMedCrossRefGoogle Scholar
  6. 6.
    Arenberg DA, Polverini PJ, Kunkel SL, et al. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukocyte Biol 1997;62:554–562.PubMedGoogle Scholar
  7. 7.
    Hunter T. Oncoprotein Networks. Cell 1997;88:333–346.PubMedCrossRefGoogle Scholar
  8. 8.
    Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Moore BB, Keane MP, Addison CL, Arenberg DA, Strieter RM. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Invest Med 1998;46:113–120.Google Scholar
  10. 10.
    Murphy PM. Viral exploitation and subversion of the immune system through chemokine minicry. Nat Immunol 2002;2:116–122.CrossRefGoogle Scholar
  11. 11.
    Rowland-Jones S, Pinheiro S, Kaul R. New insights into host factors in HIV-1 pathogenesis. Cell 2001;104:473–476.PubMedCrossRefGoogle Scholar
  12. 12.
    Whitehead IP, Zohn IE, Der CJ. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 2001;20:1547–1555.PubMedCrossRefGoogle Scholar
  13. 13.
    Dhanasekaran N, Tsim S-T, Dermott JM, Onesime D. Regulation of cell proliferation by G proteins. Oncogene 1998;17:1383–1394.PubMedCrossRefGoogle Scholar
  14. 14.
    Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of Stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000;6:3530–3535.PubMedGoogle Scholar
  15. 15.
    Kleeff J, Kusama T, Rossi DL, et al. Detection and localization of MIP-3α/LARC/EXODUS, a macrophage proin-flammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999;81:650–657.PubMedCrossRefGoogle Scholar
  16. 16.
    Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR-1/2 activate Mitogen-activated protein kinase via the Epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 2000;275:6868–6875.PubMedCrossRefGoogle Scholar
  17. 17.
    Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50–56.PubMedCrossRefGoogle Scholar
  18. 18.
    Nesbit M, Schaider H, Miller TH, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001;166:6483–6490.PubMedGoogle Scholar
  19. 19.
    Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell’Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis thorugh stromal cell-derived factor-1. Blood 2000;96:2655–2663.PubMedGoogle Scholar
  20. 20.
    Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682–4689.PubMedGoogle Scholar
  21. 21.
    Urrutia R, Dimagno EP. Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? Gastroenterology 1996;110:306–310.PubMedCrossRefGoogle Scholar
  22. 22.
    Suzuki Y, Rahman M, Mitsuya H. Diverse transcriptional response of CD4+ T cells to Stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4+ T cells. J Immunol 2001;167:3064–3073.PubMedGoogle Scholar
  23. 23.
    Driessens MHE, van Rijthoven EAM, Riviere GL, Roos E. Expression of a pertussis toxin adenosine diphosphate-ribosyltransferase in a T-cell hybridoma reduces metastatic capacity. Blood 1996;88:3116–3123.PubMedGoogle Scholar
  24. 24.
    Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001;93:1638–1643.PubMedCrossRefGoogle Scholar
  25. 25.
    Chung CY, Funamoto S, Irtel RA. Signaling pathways controlling cell polarity and chemotaxis. Trends Biol Sci 2001;26:557–566.CrossRefGoogle Scholar
  26. 26.
    Carmeleit P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–257.CrossRefGoogle Scholar
  27. 27.
    Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–395.PubMedCrossRefGoogle Scholar
  28. 28.
    Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86–89.PubMedCrossRefGoogle Scholar
  29. 29.
    Yang T-Y, Chen S-C, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by Human Herpesvirus 8 induces an angioproliferative disease resembling Kaposi’s Sarcoma. J Exp Med 2000;191:445–453.PubMedCrossRefGoogle Scholar
  30. 30.
    Kumamoto T, Huang EK, Paek HJ, Morita A, Matsue H, Valentini RF, Takashima A. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat Biotechnol 2002;20:64–69.PubMedCrossRefGoogle Scholar
  31. 31.
    Nomura T, Hasegawa H, Kohno M, Sasaki M, Fujita S. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue EBI-1-ligand chemokine and stromal cell-derived factor-1 alpha chemokine genes. J Leukocyte Biol 2001;91:597–606.Google Scholar
  32. 32.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539–545.PubMedCrossRefGoogle Scholar
  33. 33.
    Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1422–1437.CrossRefGoogle Scholar
  34. 34.
    Saurer L, Reber P, Schaffner T, Buchler MW, Buri C, Kappeler A, Walz A, Friess H, Mueller C. Differential expression of chemokines in normal pancre as and in chronic pancreatitis. Gastroenterology 2000;118:356–367.PubMedCrossRefGoogle Scholar
  35. 35.
    Sebastiano PD, di Mola FF, Febbo CD, et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000;47:423–428.PubMedCrossRefGoogle Scholar
  36. 36.
    Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966–1975.PubMedCrossRefGoogle Scholar
  37. 37.
    Barber MD, Powell JJ, Lynch SF, Fearon KCH, Ross JA. A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer. Br J Cancer 2000; 83:1443–1447.PubMedCrossRefGoogle Scholar
  38. 38.
    Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001;357:1758–1761.PubMedCrossRefGoogle Scholar
  39. 39.
    Moratti D, Faure S, Fumeron F, et al. Polymorphism in the fractalkine receptor CX3CRI as a genetic risk factor for coronary artery disease. Blood 2001;97:1925–1928.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2002

Authors and Affiliations

  1. 1.Department of Surgery, Department of Immunology, Transplantation Biology Research ProgramMayo Graduate and Medical Schools, Mayo ClinicRochester

Personalised recommendations